C
Comet Bio
Healthy and Sustainable Ingredients From Upcycled Crop Leftovers
About Comet Bio
Comet Bio operates in the health and wellness sector, specializing in the production of ARRABINA prebiotics using patented upcycling technology. The company manufactures over 4 million kilograms of ARRABINA prebiotics annually, which are versatile, fully soluble powders that dissolve clear without impacting taste. These prebiotics are used in a variety of applications including functional beverages, baked goods, confectionery, and gummies. ARRABINA prebiotics are rich in naturally occurring polyphenol antioxidants, making them an excellent complement to coffee, tea, and chocolate without altering color or taste.
Comet Bio's core product, arabinoxylan prebiotic dietary fiber, is clinically proven to support gut health and is well-tolerated by the digestive system. The company’s manufacturing facility is part of a sustainable industrial park that utilizes biomass-based steam, wind energy, and other green technologies, reflecting its commitment to sustainability.
The business model focuses on selling ARRABINA prebiotics to food and beverage manufacturers, health supplement companies, and other industries that require high-quality, functional ingredients. Revenue is generated through the sale of these prebiotic products, leveraging their unique health benefits and versatile applications to attract a broad client base.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- London, Canada
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 60.6/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Recycling, Farming, Biomass, Waste Reduction, Sustainable Development Goals, Climate Tech, Circular Economy, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jul 2021 | $22M | $88M | Sofinnova Partners · BDC Capital · Open Prairie · Louis Dreyfus Company | — |
| EARLY VC✓Equity / VC | Jul 2019 | $0 | — | Sofinnova Partners · PM Equity Partner | — |
Growth signals
Latest recorded traffic for Comet Bio is 1.5K monthly website visits, down 75.4% over the last three months. Comet Bio's team declined 27.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Sofinnova Partners- PPPM Equity Partner
Series B and later3 investors entered at this stage
Open Prairie
BDC Capital
Louis Dreyfus Company
Other known investors1 additional known investor
100+ Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Comet Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Comet Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.